Skip to main navigation

About People Science Pipeline Patients Investors Careers

Overview
Vision & Values
Impact
Founder's Letter
Contact

Overview
Leadership Team
Board of Directors
Scientific Advisory Board
R&D Advisory Board

RAS/MAPK Pathway
MAPKlamp & More
Presentations & Publications

Pipeline
Programs
Clinical Trials

Patients & Caregivers
Clinical Trials

Corporate Overview
News & Events
Stock Information
Corporate Governance
Financial Information
Investor Resources

Dynamic Culture
Values & Attributes
Competitive Benefits
Open Positions

Stay in Touch

858.465.6511
info@erasca.com

News & Events

News Releases
Erasca in the News
Events
Presentations

News Releases

Year

05.16.2024

Erasca Announces Pricing of Underwritten Offering of Common Stock

05.08.2024

Erasca Reports First Quarter 2024 Business Updates and Financial Results

05.07.2024

Erasca to Present at the Bank of America Health Care Conference

04.24.2024

Erasca Announces Three Presentations at the 2024 ASCO Annual Meeting

03.27.2024

Erasca Announces $45 Million Oversubscribed Private Placement Financing

03.27.2024

Erasca Reports Fourth Quarter 2023 and Full Year 2023 Business Updates and Financial Results

02.14.2024

Erasca Announces Two Clinical Trial Collaboration and Supply Agreements for Trametinib to Evaluate Naporafenib Combination in SEACRAFT-1 and SEACRAFT-2 Trials

02.01.2024

Erasca to Present at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference

01.03.2024

Erasca to Present at the 42nd Annual J.P. Morgan Healthcare Conference

Pagination

First page
Previous page
Page 1
Current page 2

Displaying 11 - 19 of 19

Site - Investor Tools

Contact Us

info@erasca.com

Location

ERASCA, INC.

3115 Merryfield Row

Suite 300

San Diego, CA 92121

Terms of Use
Privacy Policy

© 2021 Erasca™, Inc. All rights reserved.